NGNE
NGNE
US64135M1053
Neurogene Inc.
Loading chart...

Valuation & History

Quarterly trend of key valuation metrics

Metric
Current (TTM) TTM Baseline
Q2 '26 30.06.2026
Q1 '26 31.03.2026
Q4 '25 31.12.2025
Market & Enterprise Value
Market Cap
528.3M EUR
497.71M EUR
314.81M EUR
319.09M EUR
Enterprise Value
313.25M EUR
393.97M EUR
200.19M EUR
226.2M EUR
Valuation Multiples
Trailing P/E
--
--
--
--
Forward P/E
-4.64x
--
--
--
Price to Sales
--
--
--
--
Price to Book
1.92x
2.29x
1.32x
1.2x
EV/Revenue
--
--
--
--
EV/EBITDA
-2.66x
--
--
--
Price to FCF (P/FCF)
--
--
--
--
EV/FCF
--
--
--
--
FCF Yield
-9.1%
-17.62%
-26.43%
-17.8%
ende